Blinatumomab Effective for Children with Relapsed Leukemia - Cancer Currents Blog National Cancer Institute sent this bulletin at 04/01/2021 02:04 PM EDT Having trouble viewing this email? View it as a Web page. You are subscribed to Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Recent posts are listed below. Blinatumomab Improves Survival in Children with Relapsed Leukemia 04/01/2021 The results of two trials establish blinatumomab (Blincyto) as a new standard treatment for children and young adults with high-risk relapsed B-cell acute lymphoblastic leukemia after remission has been achieved and before a stem cell transplant.
